Yong-Hu Li, Hui Liu, Bing-Jun Yang, Lin Wang, Wen-Li Wang, Yan Ma, Amir E Kaziem, Guang-Wei Xu, Xiao-Ming Yao, Xi Huang, Gen-Zhong Cui, Hao Su, Jiwen Zhang
Aaron B Shiels, Hayden Hamby, Emma B Hanslowe, Sean Lamb, Danika R Spock, Jimmy D Taylor, David A Goldade, Katherine E Horak
{"title":"Effects of zinc phosphide bait coatings on bait consumption and mortality in gray-tailed voles (Microtus canicaudus).","authors":"Aaron B Shiels, Hayden Hamby, Emma B Hanslowe, Sean Lamb, Danika R Spock, Jimmy D Taylor, David A Goldade, Katherine E Horak","doi":"10.1002/ps.71162","DOIUrl":"10.1002/ps.71162","url":null,"abstract":"<p><strong>Background: </strong>Zinc phosphide (ZP) is one of the world's most-used rodenticides. However, ZP bait palatability can be poor and rodents may become averse to baits after ingesting sublethal amounts. Our primary objective was to determine if ZP bait coatings increased palatability and ultimately mortality of gray-tailed voles (Microtus canicaudus Miller). We offered six ZP formulations to 120 single-caged voles, including uncoated Prozap® and ZP AG® pellets and these same baits coated with powdered peanut butter or powdered cheese. A secondary objective was to determine if voles that received a sublethal dose of ZP maintained their ability to reproduce when compared to voles that were never exposed to ZP.</p><p><strong>Results: </strong>Mortality was high (75-100%) for each of the six ZP-bait formulations despite some variability in average ZP bait concentrations (2.17-2.45%). In total, 16 individuals (13.3%) survived the toxic trials, and average ZP bait consumption was alike for voles that died (0.24 g) and survived (0.23 g). All 10 pairings (five ZP-exposed pairs, five unexposed pairs) resulted in similar litter sizes and offspring mass.</p><p><strong>Conclusion: </strong>Only one ZP bait formulation (ZP AG®-uncoated) was 100% efficacious and we found no evidence that our peanut butter or cheese coatings improved mortality despite voles seemingly consuming more coated than uncoated baits. Our bait coating methodology minimized ZP dilution and is useful for evaluating future ZP bait coatings. Our findings of similar fecundity between voles exposed and unexposed to ZP highlight the importance of having toxic baits that are palatable and lethal on first exposure. Published 2026. This article is a U.S. Government work and is in the public domain in the USA.</p>","PeriodicalId":218,"journal":{"name":"Pest Management Science","volume":" ","pages":"11689-11698"},"PeriodicalIF":4.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148629006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HepatologyPub Date : 2026-12-01Epub Date: 2026-05-01DOI: 10.1097/HEP.0000000000001778
Britta Handyside, Heather Wenzel, Donald Mackenzie, Catherine Chang, Annie Greenslade, Jeremy Van Vleet, Brian Heglar, Joseph C Chen, Lening Zhang, Kevin Larimore, Huiyu Zhou, Iva Trantcheva, Lawrence Sims, Kristin Evans, Sylvia Fong, Gyanendra Kumar, Kavya Annu, Riccardo Ronzoni, James A Irving, Bing Wang, Stuart Bunting, David A Lomas
{"title":"BMN 349, a small molecule inhibitor of Z alpha-1 antitrypsin polymerization, increases secretion and reduces intrahepatic inclusions in a mouse model of disease.","authors":"Britta Handyside, Heather Wenzel, Donald Mackenzie, Catherine Chang, Annie Greenslade, Jeremy Van Vleet, Brian Heglar, Joseph C Chen, Lening Zhang, Kevin Larimore, Huiyu Zhou, Iva Trantcheva, Lawrence Sims, Kristin Evans, Sylvia Fong, Gyanendra Kumar, Kavya Annu, Riccardo Ronzoni, James A Irving, Bing Wang, Stuart Bunting, David A Lomas","doi":"10.1097/HEP.0000000000001778","DOIUrl":"10.1097/HEP.0000000000001778","url":null,"abstract":"<p><strong>Background and aims: </strong>Alpha-1 antitrypsin (AAT), encoded by the SERPINA1 gene, is primarily synthesized in the liver and secreted into the blood. The SERPINA1 Z allele encodes Z-AAT (Glu342Lys), a variant that self-associates into polymers that are retained in hepatocytes and trigger inflammation and hepatic injury. Targeting and preventing Z-AAT polymerization allows a therapy to directly address the pathophysiology of AAT deficiency (AATD) associated liver disease.</p><p><strong>Approach and results: </strong>A structure-based design approach was used to develop BMN 349, a small-molecule polymerization blocker capable of stabilizing Z-AAT to prevent new polymerization and promote hepatic clearance. BMN 349 bound Z-AAT ~150 times faster in vitro than wild-type M-AAT and promoted secretion and reduced polymer levels in a cell model of Z-AAT deficiency. Crystallography with M-AAT showed that BMN 349 partially displaces a region involved in polymerization, the reactive center loop proximal hinge. Oral dosing in female PiZ transgenic mice with 20-200 mg/kg/day BMN 349 for 30 days was associated with dose-dependent increases in total plasma Z-AAT and a concurrent decrease in circulating and liver Z-AAT polymers relative to vehicle-treated controls. Histopathologic and proteomic assessments of liver and plasma samples from these mice showed that doses ≥100 mg/kg/day of BMN 349 reduced liver inflammation and improved liver health biomarkers after 30 days.</p><p><strong>Conclusions: </strong>This study is the first to demonstrate a reduction in Z-AAT polymer burden without altering protein expression. Improvements in liver inflammation and function following BMN 349 treatment support further investigations of its therapeutic benefits for AATD liver disease.</p>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":" ","pages":"1732-1747"},"PeriodicalIF":18.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13764240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147809080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HepatologyPub Date : 2026-12-01Epub Date: 2026-06-09DOI: 10.1097/HEP.0000000000001797
Srinivasan Dasarathy, Emily P Mitchell, Laura A Wilson, Brent A Neuschwander-Tetri, Naga Chalasani, Jeanne M Clark, Anna Mae Diehl, Bilal Hameed, Rohit Loomba, Liyun Yuan, Kris V Kowdley, Arun J Sanyal
{"title":"Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.","authors":"Srinivasan Dasarathy, Emily P Mitchell, Laura A Wilson, Brent A Neuschwander-Tetri, Naga Chalasani, Jeanne M Clark, Anna Mae Diehl, Bilal Hameed, Rohit Loomba, Liyun Yuan, Kris V Kowdley, Arun J Sanyal","doi":"10.1097/HEP.0000000000001797","DOIUrl":"10.1097/HEP.0000000000001797","url":null,"abstract":"<p><strong>Background and aims: </strong>Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) is a leading cause of liver disease. Despite recent drug approvals, there is a need for low-cost therapies. Potential safety concerns regarding higher doses of vitamin E led to this study.</p><p><strong>Approach: </strong>Adults with suspected MASH, controlled attenuation parameter (CAP) score >280 dB/m on vibration-controlled transient elastography, and serum alanine aminotransferase (ALT) ≥60 U/L were randomized to 200, 400, or 800 IU of natural vitamin E (d-alpha tocopherol) or placebo once daily for 24 weeks. The primary aim was to determine the lowest effective dose of vitamin E that resulted in the greatest reduction in ALT levels from baseline to 24 weeks. Secondary aims were to assess improvements in other biomarkers of MASH, including liver fat and stiffness.</p><p><strong>Results: </strong>Two hundred participants (age 47.0+13.9 y; 62% male) completed protocol-based visits. Serum ALT levels decreased similarly compared with placebo with all 3 doses of vitamin E: -38% (200 IU), -36% (400 IU), and -36% (800 IU) compared with -12% with placebo ( p ≤0.001 for all). ALT levels normalized in more patients taking vitamin E (49%, 37%, and 50%) than with placebo (22%). AST levels also decreased significantly. Mean reduction in CAP and liver stiffness was non-significantly greater in vitamin E-treated groups. Adverse events were mild to moderate, with no life-threatening events, and similar between vitamin E and placebo.</p><p><strong>Conclusions: </strong>Vitamin E administered at 200 IU/day was as effective as other doses tested in patients with MASLD and elevated aminotransferases. No safety signals were noted.</p>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":" ","pages":"1875-1891"},"PeriodicalIF":18.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13491039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148215880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hu Sun, Yannic C R Wagner, Wieke-Marie Rosenfeldt, Rhena Schumann, Stéphanie Arrivault, Guillaume Decros, Rhiannon Page, Elizabete Carmo Silva, Tracy Lawson, Wei Huang, Alisdair R Fernie, Hermann Bauwe, Martin Hagemann, Stefan Timm
{"title":"Multi-Subunit Engineering of Photorespiratory Glycine Decarboxylase Refines Photosynthesis, Growth and Metabolic Robustness of Arabidopsis.","authors":"Hu Sun, Yannic C R Wagner, Wieke-Marie Rosenfeldt, Rhena Schumann, Stéphanie Arrivault, Guillaume Decros, Rhiannon Page, Elizabete Carmo Silva, Tracy Lawson, Wei Huang, Alisdair R Fernie, Hermann Bauwe, Martin Hagemann, Stefan Timm","doi":"10.1111/pce.70836","DOIUrl":"10.1111/pce.70836","url":null,"abstract":"<p><p>Photorespiration secures oxygenic photosynthesis from metabolic constraints arising from the oxygenation reaction of Rubisco in today's oxygen-rich atmosphere. Beyond this protective function, it is vital for primary metabolism, cellular redox balance, and stomatal regulation. Importantly, photorespiration has emerged as a key target for improving CO<sub>2</sub> assimilation and biomass production. Among proposed strategies, enhancing photorespiratory efficiency via upregulation of core enzymes has highlighted glycine decarboxylase (GDC) as a promising target, however, it remains unclear whether simultaneous upregulation of multiple GDC components would yield additive or synergistic improvements in plant environmental acclimation. Here, we systematically compared single and double GDC overexpression lines under varying photoperiods, elevated oxygen and high light. GDC upregulation consistently promoted growth across photoperiods and enhanced photosynthetic performance under high light and oxygen, indicating a severe benefit of increased photorespiratory metabolite conversion. Notably, double overexpression lines exhibited enhanced metabolic flexibility beyond that observed in single lines, supporting synergistic effects on carbon assimilation and allocation. Short-term high-light exposure further revealed increased Rubisco activity and efficient partitioning of carbon into sucrose and starch. Collectively, our results demonstrate that coordinated enhancement of GDC activity strengthens photorespiratory efficiency and can generate synergistic improvements in photosynthetic robustness, metabolic robustness, and environmental acclimation under stressful conditions. These findings position multicomponent GDC engineering as a promising strategy for developing crops with improved environmental acclimation capacity.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"9571-9585"},"PeriodicalIF":6.9,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148786310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}